Vimarsana
Biggest News Aggregation in the World

Page 2 - Video Interview Studio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Video Interview Studio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Video Interview Studio Today - Breaking & Trending Today

American Cannabis Company, Inc. Talks to The Stock Day Podcast About Its 2021 Acquisition Strategy - Vimarsana News

American Cannabis Company, Inc. Talks to The Stock Day Podcast About Its 2021 Acquisition Strategy

American Cannabis Company, Inc. Talks to The Stock Day Podcast About Its 2021 Acquisition Strategy  American Cannabis Company, Inc. DENVER, CO, Jan. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- The Stock Day Podcast welcomed American Cannabis Company, Inc. (OTCQB: AMMJ) ("the Company"), a company that offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. CEO of the Company, Terry Buffalo, joined Stock Day host Everett Jolly. Jolly commented on the Company's impressive growth over the last year, and asked about their background an...

Stock Day Media: Halberd Corporation Discusses Qualitative and Quantitative Diagnostic Methodology for Detecting COVID-19 Antibodies and Antigens with The Stock Day Podcast - Vimarsana News

Stock Day Media: Halberd Corporation Discusses Qualitative and Quantitative Diagnostic Methodology for Detecting COVID-19 Antibodies and Antigens with The Stock Day Podcast

(2) Phoenix, Arizona--(Newsfile Corp. - January 28, 2021) - The Stock Day Podcast welcomed Halberd Corporation (OTC Pink: HALB) ("the Company"), a company with a patented extracorporeal treatment applicable to many hard-to-cure blood-borne and neurological diseases, including COVID-19, other viruses, and PTSD. President and CEO of the Company, William A. Hartman, joined Stock Day host Everett Jolly. "The first part I would like to talk about is the fluorescent and non-fluorescent monoclonal antibodies. What are those exactly?" asked Jolly to begin the interview. "Antibodies work against dise...

Stock Day Media: Seafarer Exploration Corp. Discusses Discovery of Historic Material at Their Melbourne Site with The Stock Day Podcast - Vimarsana News

Stock Day Media: Seafarer Exploration Corp. Discusses Discovery of Historic Material at Their Melbourne Site with The Stock Day Podcast

(1) Phoenix, Arizona--(Newsfile Corp. - January 28, 2021) - The Stock Day Podcast welcomed Seafarer Exploration Corp. (OTC Pink: SFRX) ("the Company"), a publicly traded underwater salvage and exploration company traded under the symbol SFRX. CEO of the Company, Kyle Kennedy, and Chief Technologist, Tim Reynolds, joined Stock Day host, Everett Jolly. Jolly began the interview by asking for an update on the Company's current projects. "This last year has been extremely challenging, especially since July," shared Kennedy. "COVID-19 has not helped us any, it has made it more difficult to commu...

Stock Day Media: Nevada Exploration Inc. Discusses Phase III Drilling at Their South Grass Valley Project with The Stock Day Podcast - Vimarsana News

Stock Day Media: Nevada Exploration Inc. Discusses Phase III Drilling at Their South Grass Valley Project with The Stock Day Podcast

(2) Phoenix, Arizona--(Newsfile Corp. - January 28, 2021) - The Stock Day Podcast welcomed Nevada Exploration Inc. (OTCQB: NVDEF), (TSXV: NGE) ("the Company"), a company that has spent 15 years developing and integrating new hydrogeochemistry (groundwater chemistry) and low-cost drilling technology to build an industry-leading, geochemistry-focused, under-cover toolkit specifically to explore for new gold deposits in the more than half of Nevada where the bedrock is hidden beneath post-mineral cover. President of the Company, James Buskard, joined Stock Day host Everett Jolly. Jolly began th...

Lexaria Bioscience Corp. Discusses $11 Million Public Offering and 2021 Goals with The Stock Day Podcast - Vimarsana News

Lexaria Bioscience Corp. Discusses $11 Million Public Offering and 2021 Goals with The Stock Day Podcast

Lexaria Bioscience Corp. Discusses $11 Million Public Offering and 2021 Goals with The Stock Day Podcast The Stock Day Podcast welcomed Lexaria Bioscience Corp. a company with the proprietary drug delivery technology, DehydraTECH™, which improves the way active pharmaceutical ingredients enter the bloodstream. CEO of the Company, Chris Bunka, joined Stock Day host Everett Jolly.Jolly began the interview by congratulating Bunka on the Company’s Nasdaq Capital Market uplisting, which was announced on January 12th, … The Stock Day Podcast welcomed Lexaria Bioscience Corp. (NASDAQ: LEXX) (C...